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lateral extension, in 7/15 patients with both types of lateral 
extensions and in 1 patient with posterior lateral exten-
sion. JNA posterior lateral extension may spread behind the 
pterygoid process or between its plates. The recurrence rate 
in patients with anterior and/or posterior lateral extension 
is significantly higher than in patients with anterior lateral 
extension only. Both CT and MRI allow identification of 
the anterior and posterior lateral extensions.
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Background
Juvenile nasopharyngeal angiofibroma (JNA) is a vascu-
lar tumor that originates in the sphenopalatine foramen, at 
the area of the pterygoid canal aperture [1]. The disease is 
rare, accounting for 0.05 % of all head and neck tumors, 
and most often occurs in adolescent males [2–6]. JNA is 
a unique clinical problem due to the controversy regarding 
its exact nature, pathogenesis and best treatment option for 
most advanced tumors.
Although benign, JNA behaves aggressively, extend-
ing to the adjacent areas. From its site of origin the tumor 
grows medially to the nasopharynx, where it usually 
becomes symptomatic. Some tumors spread laterally to 
the pterygopalatine fossa and, with further growth, to the 
infratemporal fossa. JNAs with large lateral extension in 
the infratemporal fossa and cheek without medial spread to 
the nasopharynx are very rare [7].
Expanding tumor may also grow along the skull base 
posterior to the pterygoid process, which may lead to para-
pharyngeal space involvement. This type of lateral growth 
Abstract Juvenile nasopharyngeal angiofibroma is a 
benign, locally aggressive nasopharyngeal tumor. Apart 
from anterior lateral extension to the pterygopalatine fossa, 
it may spread laterally posterior to the pterygoid process, 
showing posterior lateral growth pattern, which is less com-
mon and more difficult to identify during surgery. We ana-
lyzed the routes of lateral spread, modalities useful in its 
diagnosis, the incidence of lateral extension and its influ-
ence on outcomes of surgical treatment. The records of 37 
patients with laterally extending JNA treated at our institu-
tion between 1987 and 2011 were retrospectively evaluated. 
Computed tomography was performed in all patients and 
magnetic resonance imaging in 17 (46 %) patients. CT and 
MRI were evaluated to determine routes and extension of 
JNA lateral spread. Anterior lateral extension to the ptery-
gopalatine fossa occurred in 36 (97 %) patients and fur-
ther to the infratemporal fossa in 20 (54 %) patients. In 16 
(43 %) cases posterior lateral spread was observed: poste-
rior to the pterygoid process and/or between its plates. The 
recurrence rate was 29.7 % (11/37). The majority of resid-
ual lesions was located behind the pterygoid process (7/11). 
Recurrent disease occurred in 3/21 patients with anterior 
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should be identified as a posterior lateral extension, in con-
trast to the anterior lateral extension in the pterygopalatine 
fossa, which is more common and easier to identify during 
surgery. Extranasopharyngeal extensions of JNA include 
also the nasal cavity, paranasal sinuses, the orbit and in 
advanced cases also the cranium.
Surgical removal is the gold standard treatment for 
extracranial angiofibromas [5, 6, 8]. Extranasopharyngeal 
extensions may increase the risks of surgical treatment due 
to potential complications of wide surgical exposure, intra-
operative hemorrhage and recurrence. In this context, the 
problem of the posterior lateral extension is of particular 
interest.
The aim of this study was to analyze radiological find-
ings of JNA patients with lateral extension with special 
attention given to routes of lateral spread and modalities 
useful in its diagnosis. The incidence of lateral spread and 
its influence on planning and outcomes of surgical treat-
ment were also discussed.
Materials and methods
A retrospective chart review of 47 patients with juvenile 
nasopharyngeal angiofibroma referred to our institution 
between 1987 and 2011 was performed. The records of 37 
patients with tumors extending laterally from the nasophar-
ynx were included in the study. The study was approved by 
the institutional ethical committee.
All patients in the selected group were males. The age 
ranged from 9 to 30 years (the median age was 16 years). 
Most common presenting symptoms were nasal obstruc-
tion in 34 of 37 patients (92 %) and epistaxis in 32 of 37 
patients (86 %). Additional complaints were facial swelling 
in four patients and proptosis in two patients. The duration 
of symptoms ranged from 2 to 24 months.
Preoperative imaging workup included contrast-
enhanced computed tomography (CT) in all cases and 
magnetic resonance imaging (MRI) in 17 (46 %) cases. 
In 20 patients MRI was not performed, because they were 
diagnosed before MRI was available at our institution or 
information provided by CT was sufficient for the surgeon. 
Twenty nine CT and 14 MRI studies were performed at our 
institution and the radiological equipment included 32-slice 
scanner system Lightspeed PRO32 and 64 slice CT scan-
ner system (both GE Healthcare global imaging, Dewau-
kee, WI, USA) and two 1.5 T MRI systems: Edge Eclipse 
(Picker International Inc, Cleveland, Ohio, USA) and Mag-
netom Avanto (Siemens AG, Munchen, Germany). The 
remaining patients had imaging studies from referring insti-
tutions performed on different types of MR and CT scan-
ners. Although some scanning parameters varied, all MR 
studies were performed on 1.5 T systems, with multipla-
nar imaging using unenhanced T2-weighted, T1-weighted 
and gadolinium-enhanced T1-weighted sequences. In all 
patients CT scans with contrast-enhanced axial sections 
were available.
Carotid angiography was performed in all cases and pre-
operative embolization in 27/37 (72.9 %) cases.
Two radiologists reviewed the CT and MR images to 
determine the routes and extension of JNA lateral spread 
and compare the usefulness of CT and MRI for depicting 
this growth direction. Images were analyzed for erosion 
and dislocation of bony structures, widening of the foram-
ina of the cranial base, obliteration of normal fatty spaces 
and tumor contrast enhancement. All tumors were staged 
according to Andrews classification [9].
Six patients presented with recurrent tumors after opera-
tions in other hospitals. All 37 patients underwent surgical 
treatment at our institution and were operated on by two 
main surgeons. Statistical analysis of recurrence rates in 
patients with various types of lateral extensions was per-
formed (χ2 test with Yates correction).
Results
Thirty-seven patients with laterally extending JNA were 
included in this study. According to Andrews classification, 
14 (38 %) patients had stage II, 15 (40 %) had stage IIIa, 
6 (16 %) had stage IIIb, 1 (3 %) had stage IVa and another 
(3 %) had stage IVb. Tumor radiological extensions in the 
presented group are displayed in Table 1. Intracranial spread 
occurred in 1 of 21 (4.7 %) patients with only anterior lat-
eral extension (group A) and in 7 of 15 (53.3 %) patients 
with both types of lateral extensions (group B) (Table 2).
Table 1  Tumor radiological extensions in the 37 presented cases
Anterior lateral extension 36/37 (97 %) Posterior lateral extension 16/37 (43 %) Other
36/37 (97 %): pterygopalatine fossa 7/37 (19 %): between pterygoid plates 8 (22 %): intracranial
34 (91.8 %): vidian canal
20/37 (54 %): infratemporal fossa 4/37 (11 %): posterior to the pterygoid process 15 (40 %): cancellous bone at the pterygoid base
5/37 (13 %): both types 8 (22 %): orbit
4 (11 %): cheek
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Routes of lateral spread
In 36/37 (97 %) patients tumor spread laterally to the ptery-
gopalatine fossa showing anterior lateral spread pattern 
(Fig. 1). Of these, in 20 (54 %) patients further growth into 
the infratemporal fossa was stated.
In 16/37 (43 %) cases, posterior lateral spread with 
growth vector directed posteriorly to the pterygoid process 
was observed. In 7/37 (19 %) patients tumor eroded the 
pterygoid process and extended laterally between its plates. 
In 4/37 (11 %) patients, lateral extension posterior to the 
pterygoid process was found. In 5/37 (13 %) cases, both 
the above-mentioned ways of posterior lateral spread were 
stated (Table 1) (Fig. 2).
Of the whole group, in 21/37 (56.8 %) patients only 
anterior lateral spread was observed. Fifteen (40.5 %) 
patients had both anterior and posterior lateral exten-
sions and one patient had only posterior lateral extension 
(Table 2).
Radiological findings
In 36/37 (97 %) patients, anterior bowing of the posterior 
maxillary wall and tumor involvement of the pterygopala-
tine fossa were observed. CT showed erosion of the ptery-
goid process and widening of the sphenopalatine foramen 
in 36/37 (97 %) cases. Advanced destruction of the ptery-
goid process was stated in 20/37 (54 %) patients. In 15/37 
(40 %) patients, tumor invaded cancellous bone at the base 
of the pterygoid process or the greater wing of the sphenoid 
(Fig. 3). Involvement of the Vidian canal occurred in 34/37 
(91.8 %) patients in the whole group, including 18/21 
(85.7 %) with anterior lateral extension and all 16 (100 %) 
patients with anterior and/or posterior lateral extension.
All CT and MR images showed intensive tumor 
enhancement after contrast administration. Both modalities 
Table 2  Summary of types of lateral extensions, intracranial spread and tumor recurrences in the presented cases
PP pterygoid process
Total number  
of patients
Localization of the lateral extension Intracranial spread  
no. (%)
Recurrences
No (%) Type of lateral extension No. (%) Location
37 21/37 (56.8 %) Anterior (group A) 1/21 (4.7 %) 3/21 (14.2 %) 3-Pterygoid base
15/37 (40.5 %) Anterior and posterior (group B) 8/15 (53.3 %) 7/15 (46.6 %) 6-Posterior to PP
1-Intracranial
1/37 (2.7 %) Posterior (group C) – 1 1-Posterior to PP
Fig. 1  Contrast-enhanced axial CT scan indicates forward displace-
ment of the posterior maxillary wall (arrow) and tumor invasion of 
the pterygopalatine fossa (asterisk) Fig. 2  Contrast-enhanced axial CT scan well demonstrates three routes of tumor lateral spread in a case of extensive JNA: into the 
pterygopalatine and infratemporal fossa (asterisk), posterior to the 
pterygoid process (curved arrow) and between its plates (arrow-
heads)
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in all cases well depicted the presence of anterior lateral 
extension and in all cases allowed the identification of the 
posterior lateral spread. However, the relationship of pos-
terior lateral extensions to the eroded and displaced ptery-
goid process was better demonstrated on CT scans than on 
MRI. Both methods allowed accurate delineation of tumor 
margins and the extension of the posterior lateral spread, 
as well as anterior lateral spread in the pterygopalatine and 
infratemporal fossa. Both CT and MRI allowed visualiza-
tion and precise definition of the medullary bone involve-
ment of the sphenoid.
Surgical treatment and outcomes
Surgical treatment was applied in 37 cases. The following 
approaches were used: transpalatal in 6 cases, sublabial 
degloving in 20 cases and infratemporal fossa approach 
in 5 cases. In six patients endoscopic resection was per-
formed. Follow-up ranged 1–25 years. In all patients the 
diagnosis of JNA was histopathologically confirmed.
The recurrence rate was 29.7 % (11/37). Residual tumor 
was located at the base of the pterygoid process in 3/11 
(27.2 %) patients and posteriorly to the pterygoid process 
in 7/11 (63.6 %) patients (including three patients with per-
sistent lesion located between the pterygoid plates) (Fig. 4). 
One patient (1/11–9.0 %) had a residual intracranial exten-
sion, which was removed in a second-stage neurosurgi-
cal operation. Except for one case of asymptomatic stable 
residual mass under 10 years follow-up, all residual tumors 
were successfully surgically removed.
Recurrent disease was observed in 3 out of 21 (14.2 %) 
patients with anterior lateral extension via the pterygo-
palatine fossa, in 7 out of 15 (46.6 %) patients with both 
types of lateral extensions and in 1 patient with exclusively 
posterior lateral extension (Table 2). The recurrence rate 
in patients with posterior lateral extension and both types 
of lateral spread (groups B and C) was significantly higher 
than in patients with anterior lateral extension only (group 
A) (p < 0.05).
Surgery included drilling of the vidian canal and basis 
sphenoid in 27/37 patients with tumor involvement of these 
structures. In the remaining 10/37 cases, available medical 
records did not contain detailed surgical information about 
drilling of this area; therefore its potential influence on the 
recurrence rate could not be assessed. However, the three 
cases of residual tumor at the pterygoid base occurred in 
the latter group.
Discussion
JNAs show locally invasive nature and tend to extend into 
the natural foramina, fissures and sinus compartments.
From the area of the sphenopalatine foramen, the tumor 
grows laterally to the pterygopalatine fossa and with fur-
ther progression to the infratemporal fossa, through the 
enlarged pterygomaxillary fissure. This extension results 
in a widening of the sphenopalatine foramen and anterior 
bowing of the posterior maxillary wall, with or without 
posterior displacement of the pterygoid process [4, 10, 
11]. These features together with erosion of the pterygoid 
process and enhancing tumor mass in the nasopharynx 
and pterygopalatine fossa are characteristic signs of JNA. 
Fig. 3  Coronal CT scan indicates extensive involvement and expan-
sion of the pterygoid base and greater sphenoid wing diploë (arrow-
heads) with erosion of the skull base (arrow)
Fig. 4  Axial contrast-enhanced T1-weighted MR image with fat 
saturation demonstrates residual tumor between the pterygoid plates 
(arrowheads)
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In our experience these radiological findings are well rec-
ognized on both CT and MRI. While CT provides precise 
definition of bony changes, MRI allows better evaluation of 
the intracranial spread, as well as superior differentiation 
between tumor mass and mucosal swelling or fluid reten-
tion in paranasal sinuses.
Lateral extension of the tumor to the pterygopalatine 
fossa is a common finding. It was reported by Rekonnen 
et al. [6] in 25.9 % of cases, Economou et al. [12] in 53 % 
of cases and Antonelli et al. [13] in 73 % of cases. In our 
study initial evaluation of 47 patients treated at our institu-
tion between 1987 and 2011 revealed the presence of tumor 
in the fossa pterygopalatine in 76.5 % of patients and further 
involvement of the infratemporal fossa in 54 % of patients.
Although tumor growth pattern with tendency to occupy 
the pterygopalatine fossa has been well described, few 
authors present cases of JNA with lateral spread posterior 
to the pterygoid process. This route of lateral growth was 
observed in 2 of 23 cases (9 %) reported by Radkowski 
et al. [14] and in 8 of 20 cases (40 %) reported by Hyun 
et al. [3]. In our study apart from lateral spread posterior 
to the pterygoid process, we identified route of spread 
between pterygoid plates, which was an apparent source of 
residual disease in three patients. Our primary retrospective 
evaluation of 47 patients with JNA treated at our institution 
revealed the presence of lateral extension posterior to the 
pterygoid process and/or between its plates in 16 (34 %) 
patients. In the analyzed group of 37 patients with lateral 
spread, almost half of patients (40.5 %) presented with both 
anterior and posterior lateral extensions. Our results show 
that posterior lateral extension usually follows anterior lat-
eral spread, but rarely it may be observed without involve-
ment of the pterygopalatine fossa.
In contrast to anterior lateral spread to the pterygopala-
tine fossa, posterior lateral extension occurs less frequently 
and is more difficult to identify due to variable patterns of 
tumor expansion and bony changes at the area of the ptery-
goid process. Therefore, some small lesions may be missed 
on imaging studies. The surgical implications of the poste-
rior lateral spread demand a thorough evaluation of tumor 
extensions posterior and/or between pterygoid plates. In 
our experience, contrast-enhanced CT and MRI both allow 
identification of the posterior lateral extension. However, 
precise evaluation of the relationship between tumor exten-
sions and displaced/eroded pterygoid process requires the 
best bone imaging available, provided by CT. This modal-
ity also provides the surgeon with precise visualization of 
the anatomical bony landmarks.
It is generally accepted that surgical resection is the 
treatment modality of choice for JNA [15]. When choos-
ing the surgical approach the following points should be 
considered: adequate exposure of tumor extensions, vas-
cular control of the tumor and minimal invasiveness with 
respect to soft tissue and bony disruption. Various surgical 
methods have been used for complete and safe resection 
of JNAs. The four approaches used at our institution were 
transpalatal approach, midfacial degloving, the infratempo-
ral fossa approach and endoscopic technique. Transpalatal 
approach is best suited for tumors limited to the nasophar-
ynx, nasal cavity and sphenoid sinuses. It has an advantage 
of no facial incisions, but the main drawback is limited 
lateral exposure. At our institution it has been replaced by 
endoscopic removal. Midfacial degloving allows resection 
of tumors invading paranasal sinuses, orbit, pterygopala-
tine and infratemporal fossae, except for lesions with large 
infratemporal fossa extensions (up to temporal fossa) [8, 
15]. Due to the use of sublabial and intranasal incisions, 
it allows good surgical exposure without facial scars. The 
infratemporal fossa approach provides access to most 
extensive tumors, involving the infratemporal fossa, mid-
dle cranial fossa and lateral part of the cavernous sinus. It 
allows wide exposure of the skull base and visualization of 
the dura and the cavernous sinus. The main disadvantage 
is its invasiveness with the risk of conductive hearing loss 
on the operated site, the injury of the mandibular division 
of the trigeminal nerve, facial asymmetry and growth retar-
dation [9, 16, 17]. In recent years, endoscopic approaches 
have made a significant improvement in the management 
of JNAs. Transnasal resection has all the advantages of 
endoscopic surgery, such as minimal bleeding, mini-
mal invasiveness, lower morbidity and complications rate 
and lower risk of recurrence in comparison to traditional 
approaches [18–20]. Initially indicated only in early stage 
angiofibromas, currently endoscopic technique is used for 
the management of selected cases of tumors expanding to 
the pterygopalatine fossa and infratemporal fossa [6, 15, 
21]. Contraindications for exclusively endoscopic approach 
with the goal for total resection include lateral infratem-
poral extension, large intracranial extension, intracranial 
extension laterally to the cavernous sinus, encasement of 
the internal carotid artery (ICA), abundant supply from the 
ICA, significant involvement of the cavernous sinus and 
extension to the cheek [6, 8, 10, 22]. In endoscopic surgery, 
removal of the posterior wall of the maxillary sinus during 
surgery provides excellent exposure of the pterygopalatine 
fossa and medial part of the infratemporal fossa, enabling 
tumor extirpation. In contrast to anterior lateral growth, 
posterior lateral extension is more difficult to find during 
operation [23] (Fig. 5). This type of lateral spread, poste-
rior to the pterygoid process, into the region of the medial 
and lateral pterygoid muscles, was first described by Rad-
kowski et al. [14]. He was also the first to emphasize the 
importance of this extension as a factor increasing the risk 
of subtotal resection.
Recurrent disease is common in the management 
of JNAs and recurrence rates vary from 13 % to 46 % 
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depending on tumor stage and surgical approach [20, 24, 
25]. JNA is a benign lesion and many investigators agree 
that most recurrences can be attributed to incomplete 
removal [6, 8, 26, 27]. In our study recurrent disease was 
stated in 29.7 % (11/37) of cases. More than a half of resid-
ual tumors (7/11) were located posterior to the pterygoid 
process. It was the most common location of the persistent 
disease in the whole analyzed group and almost the only 
source of tumor recurrence in patients with posterior lateral 
extension and both types of lateral spread. The recurrence 
rate in patients with posterior lateral spread and both types 
of lateral extension was significantly higher than in the 
group, where only anterior lateral extension was present.
Several staging systems based on JNA extension have 
been proposed. In all classifications, tumor lateral exten-
sion to the pterygopalatine and infratemporal fossa reflects 
medium advancement of the disease—stage II and/or stage 
III. Radkowski et al. [14] were the first to propose a revised 
staging system stressing the presence of extension posterior 
to the pterygoid plates as a higher risk factor of persistent 
disease. More recently, Onerci et al. [23] suggested a modi-
fied classification system including tumor extension poste-
rior to the pterygoid plates, which more accurately reflected 
the increased difficulty of complete excision (Table 3). 
On the basis of the significant difference in the recurrence 
rates, we believe that the presence of posterior lateral exten-
sion is clinically more important than the anterior lateral 
spread as an indicator of possible recurrence. Moreover, 
tumor extending posterior to the pterygoid process grows in 
proximity to the natural channels in the skull base, which 
represent the natural pathway of intracranial invasion. In 
our study, intracranial spread was observed in 53.3 % of 
patients with both anterior and posterior lateral extension, 
and in 4.7 % of patients with only anterior lateral spread. 
Our results support the classification system by Onerci 
et al. [23], where lateral spread posterior to the pterygoid 
plates represents higher stage of the disease, associated with 
increased risk of recurrence, than anterior lateral extension.
Lateral spread of JNA may be followed by two types of 
bony changes: pressure erosion and displacement of the 
Fig. 5  Axial CT scan after application of contrast medium shows 
small, submucosal residual tumor between the pterygoid plates 
(arrows)
Table 3  Synopsis of staging systems for JNA
Andrews et al. 1989 [9]
 (I) Tumor limited to the nasopharynx and nasal cavity. Bone destruction negligible or limited to the sphenopalatine foramen
 (II) Tumor invading the pterygomaxillary fossa or the maxillary, ethmoid or sphenoid sinus with bone destruction
 (III) A. Tumor invading the infratemporal fossa or orbital region without intracranial involvement
B. Tumor invading the infratemporal fossa or orbit with intracranial extradural (parasellar) involvement
 (IV) A. Intracranial intradural tumor without infiltration of the cavernous sinus, pituitary fossa or optic chiasm
B. Intracranial intradural tumor with infiltration of the cavernous sinus, pituitary fossa or optic chiasm
Radkowski et al. 1996 [14]
 (I) A. Tumor limited to the nose and/or nasopharyngeal vault
B. Extension into one or more sinuses
 (II) A. Minimal extension into the pterygomaxillary fossa
B. Full occupation of the pterygomaxillary fossa with or without erosion of the orbital bones
C. Infratemporal fossa with or without cheek or posterior to the pterygoid plates
 (III) A. Erosion of the skull base—minimal intracranial extension
B. Erosion of the skull base—extensive intracranial extension with or without cavernous sinus invasion
Onerci et al. 2006 [23]
 (I) Nose, nasopharyngeal vault, ethmoidal-sphenoidal sinuses or minimal extension to PMF
 (II) Maxillary sinus, full occupation of PMF, extension to the anterior cranial fossa and limited extension to the infratemporal fossa
 (III) Deep extension into the cancellous bone at the base of the pterygoid or the body and the greater wing of the sphenoid, significant lateral 
extension to the infratemporal fossa or to the pterygoid plates posteriorly or orbital region, cavernous sinus obliteration
 (IV) Intracranial extension between the pituitary gland and internal carotid artery, tumor localization lateral to the internal carotid artery, mid-
dle fossa extension and extensive intracranial extension
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pterygoid process and the posterior maxillary wall or direct 
involvement of cancellous bone at the base of the pterygoid 
process [4, 21]. The second growth pattern with further 
spread and involvement of the sphenoid diploë may result 
in the destruction of the inner table of the skull base and 
invasion of the middle cranial fossa.
Additionally, locally aggressive growth in this area 
makes complete surgical removal more difficult and 
increases the risk of residual/recurrent disease. Lloyd 
et al. [4] first indicated that the involvement of the cancel-
lous bone at the pterygoid base is closely associated with 
incomplete tumor removal. He reported that 93 % of recur-
rences occurred in this group and multiple recurrences were 
associated with this type of extension. In our study the base 
of the pterygoid process was the second main source of 
tumor regrowth and the only location of the recurrent dis-
ease in patients with only anterior lateral extension. Three 
of 11 (27.2 %) residual tumors were observed in this loca-
tion. Therefore, thorough evaluation of tumor spread at 
the pterygoid base is particularly important in preopera-
tive diagnostic management. Both CT and MRI are used to 
determine the extent of tumor extension within the sphe-
noid bone. Coronal and axial plane MR images, especially 
with fat saturation techniques and intravenous contrast 
injection, are considered more accurate in depicting medul-
lary bone involvement [21].
Conclusions
1. Apart from the common anterior lateral extension to 
the pterygopalatine fossa, JNAs may present less fre-
quent posterior lateral growth pattern along the skull 
base behind the pterygoid process or between the 
plates.
2. In tumors extending laterally the most common source 
of residual disease is posterior lateral extension behind/
between the pterygoid plates. The recurrence rate in 
patients with posterior lateral extension and both types 
of lateral spread is significantly higher than in patients 
with anterior lateral extension only.
3. Both CT and MRI are valuable tools for detection 
of the lateral extension in the pterygopalatine and 
infratemporal fossa, as well as involvement of the 
pterygoid base. The exact relationship of posterior 
lateral extension, which may decrease the efficacy of 
minimally invasive surgery, to the eroded pterygoid 
process is more obvious on CT scans.
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